Blood Glucose Monitoring Devices Market Size, Share & Trends by 2034

Blood Glucose Monitoring Devices Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Self-Monitoring Devices, Continuous Blood Glucose Monitoring Devices); End User (Hospitals, Home care, Diagnostic centers) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00021559
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Blood Glucose Monitoring Devices Market Size, Share & Trends by 2034
Report Date: Jul 2026   |   Report Code: TIPRE00021559 Email: sales@theinsightpartners.com
Buy Now

Blood Glucose Monitoring Devices market is expected to register a CAGR of 7.05% from 2026 to 2034, with the market size expanding from US$ 18.61 Billion in 2025 to US$ 34.37 Billion by 2034.

The report is segmented by Product (Self-Monitoring Devices, Continuous Blood Glucose Monitoring Devices). Futher, it is segmented based on End User (Hospitals, Home care, Diagnostic Centers). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.

Purpose of the Report

The report Blood Glucose Monitoring Devices Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Blood Glucose Monitoring Devices Market Segmentation

Product

  • Self-Monitoring Devices
  • Continuous Blood Glucose Monitoring Devices

End User

  • Hospitals
  • Home care
  • Diagnostic Centers

Market Research Highlights

  • Global market for Blood Glucose Monitoring Devices was valued at US$ 18.61 Billion in 2025
  • Annual market size is expected to reach US$ 34.37 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 239.12 Billion
  • Market is anticipated to register a CAGR of 7.05% during the forecast period
  • The United States represents a key market, supported by Rising Prevalence of Diabetes, Increased Health Awareness, Technological Advancements, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Government Initiatives and Support, Preventive Healthcare Will Create More Demand for Blood Glucose Monitoring Devices, Development of Non-Invasive Monitoring Solutions are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, BD, Insulet Corporation, Dexcom, Inc., Sanofi, Elly Lilly and Company, Novo Nordisk A/S, while analyzing competitive strategies and innovation developments

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Blood Glucose Monitoring Devices Market: Strategic Insights

blood-glucose-monitoring-devices-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Blood Glucose Monitoring Devices Market Growth Drivers

  • Rising Prevalence of Diabetes: Because the prevalence of diabetes is on the rise, especially due to sedentary lifestyles and poor eating habits, patients are requiring more effective blood glucose monitoring devices. This emerging need creates an expectation for innovative solutions to assist patients in managing their condition.
  • Increased Health Awareness: There has been an increase in diabetes awareness and management and regular glucose monitoring towards the consumers purchasing dependable glucose monitoring devices. Such factors are also influenced by the education campaigns and programs undertaken by the health care providers.
  • Technological Advancements: The never-ending growth of technology, for instance, the invention of CGM systems and integration of smart devices, has improved the experience and precision of users. These enhancements are making it easier and more interesting to keep track of things, thus facilitating the growth of the market.

Blood Glucose Monitoring Devices Market Future Trends

  • Increasing Wearable Technology: Wearable technology is transforming blood glucose monitoring. Those wearables that can be used discreetly and non-stop are gaining popularity as they provide immediate glucose values and compliance to monitoring protocols.
  • Trend Towards Personalized Diabetes Management: It is switching towards personalized diabetes management, such as with devices providing customized suggestions based on individual user data. This ensures optimal efficacy of treatment and enables a patient to manage their health more effectively.
  • Remote Patient Monitoring: Remote patient monitoring has been gaining pace after the pandemic. Blood glucose monitors allowing practitioners to conduct telehealth consultations while pulling in patient data from virtually anywhere are becoming the root of diabetes treatments.

Blood Glucose Monitoring Devices Market Opportunities

  • Government Initiatives and Support: Various government initiatives, such as the betterment of diabetes care and management, provide impetus to the growth in the market. Subsidies, reimbursement policies, and public health programs regarding prevention and management of diabetes encourage blood glucose monitoring devices.
  • Preventive Healthcare Will Create More Demand for Blood Glucose Monitoring Devices: Prevention of diseases is gaining popularity, thus advocating for blood glucose monitoring devices that will support the early detection and control of diabetics. Therefore, as an aspect of this, players in the market can create educational aids and appliances that aim to encourage consumers to take care of their health.
  • Development of Non-Invasive Monitoring Solutions: This is more obvious with regard to non-invasive blood glucose monitoring solutions. Putting resources into research and development can also be a strategy to come up with the new painless devices for monitoring in this case an irresistible offer to the consumers who are always on the lookout for easy to use and more importantly comfortable devices.

Blood Glucose Monitoring Devices Market Report Scope

Report Attribute Details
Market size in 2025 US$ 18.61 Billion
Market Size by 2034 US$ 34.37 Billion
Global CAGR (2026 - 2034) 7.05%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Self-Monitoring Devices
  • Continuous Blood Glucose Monitoring Devices
By End User
  • Hospitals
  • Home care
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • BD
  • Insulet Corporation
  • Dexcom, Inc.
  • Sanofi
  • Elly Lilly and Company
  • Novo Nordisk A/S

Blood Glucose Monitoring Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Blood Glucose Monitoring Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

blood-glucose-monitoring-devices-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Glucose Monitoring Devices Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Blood Glucose Monitoring Devices Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The major factors driving the blood glucose monitoring devices market are:

1. Rising Prevalence of Diabetes.

2. Increased Health Awareness.

North America region accounts for highest revenue share in blood glucose monitoring devices market.

Asia Pacific is estimated to grow at the highest CAGR of 7.05% from 2026 to 2034

The blood glucose monitoring devices market is expected to grow at a CAGR of 7.05% from 2026 to 2034

The final report will duly include market size along with CAGR of 7.05% from 2026 to 2034

Abbott Laboratories, Medtronic, and Bayer AG are the major companies operating in the blood glucose monitoring devices market.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Jan 2025